Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients.
Lapadula G, Costarelli S, Chatenoud L, Castelli F, Astuti N, Di Giambenedetto S, Quiros-Roldan E, Sighinolfi L, Ladisa N, Di Pietro M, Zoncada A, Di Filippo E, Gori A, Nasta P, Torti C; Italian MASTER Cohort. Lapadula G, et al. Among authors: ladisa n. J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):312-8. doi: 10.1097/QAI.0000000000000585. J Acquir Immune Defic Syndr. 2015. PMID: 25723139
Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART.
Lapadula G, Chatenoud L, Gori A, Castelli F, Di Giambenedetto S, Fabbiani M, Maggiolo F, Focà E, Ladisa N, Sighinolfi L, Di Pietro M, Pan A, Torti C; Italian MASTER Cohort. Lapadula G, et al. Among authors: ladisa n. PLoS One. 2015 May 28;10(5):e0124741. doi: 10.1371/journal.pone.0124741. eCollection 2015. PLoS One. 2015. PMID: 26020949 Free PMC article.
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.
Torti C, Maggiolo F, Patroni A, Suter F, Ladisa N, Paraninfo G, Pierotti P, Orani AM, Minoli L, Arici C, Sighinolfi L, Tinelli C, Carosi G; MASTER Cohort. Torti C, et al. Among authors: ladisa n. J Antimicrob Chemother. 2005 Jul;56(1):190-5. doi: 10.1093/jac/dki172. Epub 2005 May 25. J Antimicrob Chemother. 2005. PMID: 15917286
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort.
Torti C, Lapadula G, Puoti M, Casari S, Uccelli MC, Cristini G, Bella D, Pastore G, Ladisa N, Minoli L, Sotgiu G, Caputo SL, Bonora S, Carosi G. Torti C, et al. Among authors: ladisa n. J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):180-5. doi: 10.1097/01.qai.0000192005.08153.a3. J Acquir Immune Defic Syndr. 2006. PMID: 16394850
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
Torti C, Lapadula G, Barreiro P, Soriano V, Mandalia S, De Silvestri A, Suter F, Maggiolo F, Antinori A, Antonucci F, Maserati R, El Hamad I, Pierotti P, Sighinolfi L, Migliorino G, Ladisa N, Carosi G; Italian MASTER Cohort. Torti C, et al. Among authors: ladisa n. J Antimicrob Chemother. 2007 Jun;59(6):1141-7. doi: 10.1093/jac/dkm100. Epub 2007 Apr 13. J Antimicrob Chemother. 2007. PMID: 17434879
Predictors of AIDS-defining events among advanced naïve patients after HAART.
Torti C, Lapadula G, Maggiolo F, Casari S, Suter F, Minoli L, Pezzoli C, Pietro MD, Migliorino G, Quiros-Roldan E, Ladisa N, Sighinolfi L, Gatti F, Carosi G; Italian MASTER Cohort. Torti C, et al. Among authors: ladisa n. HIV Clin Trials. 2007 May-Jun;8(3):112-20. doi: 10.1310/hct0803-112. HIV Clin Trials. 2007. PMID: 17621458
114 results